• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I FREE T4 REAGENT KIT; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I FREE T4 REAGENT KIT; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Catalog Number 07P70-20
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/31/2024
Event Type  malfunction  
Manufacturer Narrative
Completed information for section a1 patient identifier: sid (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed falsely elevated alinity i free t4 results for a 84 year old male patient.The patient was previously diagnosed with hypothyroidism in (b)(6) 2022 and was started on the medication thyradin.The following information was provided (customer provided reference ranges: free t4 is 0.70 to 1.48 ng/dl, tsh is 0.35 to 4.94 uiu/ml): (b)(6) 2024: free t4 = 2.66 ng/dl, repeat at another laboratory generated results within the normal range, free t3 = 2.51, tsh = 6.22 uiu/ml.(b)(6) 2024 sid (b)(6) : free t4 = 1.27 ng/dl, repeat = 0.86 ng/dl.Free t3 = 2.27, repeat = 2.12.Tsh = 4.93 uiu/ml, repeat = 6.08 uiu/ml.Patient history (cardiovascular examinations with chf, hypertension, and ischemic heart disease) and historical results: (b)(6) 2022: tsh = 20.23 uiu/ml, free t4 = 0.84 ng/dl, free t3 = 2.36.The patient was referred to the current department and diagnosed with hypothyroidism and started on thyradin 12.5 ug.(b)(6) 2022: the patient didn¿t have a repeat visit and the medication was discontinued.(b)(6) 2023: tsh = 6.88 uiu/ml, free t4 = 1.29 ng/dl.(b)(6) 2023: tsh = 16.34 uiu/ml, free t4 = 0.98 ng/dl.The patient was restarted on thyradin 12.5 ug.(b)(6) 2023: tsh = 16.37 uiu/ml, free t4 = 1.11 ng/dl.The thyradin was increased to 25 ug.(b)(6) 2023: tsh = 4.95 uiu/ml, free t4 = 1.36 ng/dl.(b)(6) 2023: tsh = 2.8 uiu/ml, free t4 = 1.68 ng/dl.The thyradin was reduced to 12.5/25 ug every other day.The customer is questioning the alinity i free t4 results generated on (b)(6) 2024 and (b)(6) 2024.The patient¿s medication has not changed due to the falsely elevated alinity i free t4 results.The customer is not questioning the alinity i tsh results.No impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I FREE T4 REAGENT KIT
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key19070454
MDR Text Key339879528
Report Number3005094123-2024-00176
Device Sequence Number1
Product Code CEC
UDI-Device Identifier00380740121815
UDI-Public(01)00380740121815(17)240503(10)51650UD00
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K173122
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/03/2024
Device Catalogue Number07P70-20
Device Lot Number51650UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/21/2024
Initial Date FDA Received04/09/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/16/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
Patient Age84 YR
Patient SexMale
-
-